| |
| |
|
| Insider
Information: |
Biller Scott |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,729 |
|
|
Indirect Shares
|
53,059 |
|
|
| Direct
Value |
$1,592,683 |
|
|
|
Indirect Value
|
$2,505,446 |
|
|
| Total
Shares |
86,788 |
|
|
| Total
Value |
$4,098,129 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Scientific Officer |
2019-06-11 |
33,729 |
2019-06-11 |
53,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
121 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-08-01 |
4 |
OE |
$9.05 |
$19,421 |
D/D |
2,146 |
8,410 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-08-02 |
4 |
AS |
$60.06 |
$1,261,260 |
I/I |
(21,000) |
25,470 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-09-11 |
4 |
AS |
$65.00 |
$975,000 |
I/I |
(15,000) |
10,470 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-10-02 |
4 |
AS |
$67.23 |
$144,276 |
D/D |
(2,146) |
6,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-10-02 |
4 |
OE |
$9.05 |
$40,995 |
D/D |
2,146 |
7,219 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-10-04 |
4 |
AS |
$70.00 |
$732,900 |
I/I |
(10,470) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-11-01 |
4 |
AS |
$61.81 |
$134,522 |
D/D |
(2,146) |
6,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-11-01 |
4 |
OE |
$31.64 |
$67,899 |
D/D |
2,146 |
8,410 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-12-01 |
4 |
AS |
$59.89 |
$130,459 |
D/D |
(2,146) |
6,264 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-12-01 |
4 |
OE |
$31.64 |
$67,899 |
D/D |
2,146 |
8,410 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2017-12-06 |
4 |
OE |
$0.47 |
$81,376 |
D/D |
46,795 |
53,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-01-10 |
4 |
AS |
$65.00 |
$195,000 |
D/D |
(3,000) |
53,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-01-10 |
4 |
OE |
$0.47 |
$1,403 |
D/D |
3,000 |
56,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-02-05 |
4 |
AS |
$74.89 |
$228,128 |
D/D |
(3,000) |
53,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-02-05 |
4 |
OE |
$0.47 |
$26,601 |
D/D |
3,000 |
56,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-03-05 |
4 |
AS |
$80.93 |
$249,229 |
D/D |
(3,000) |
53,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-03-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
56,059 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-03-28 |
4 |
OE |
$0.47 |
$9,611 |
D/D |
4,137 |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-04-05 |
4 |
AS |
$73.90 |
$225,607 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-04-05 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-07 |
4 |
AS |
$81.81 |
$245,430 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-07 |
4 |
OE |
$9.05 |
$27,150 |
D/D |
3,000 |
60,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
AS |
$90.00 |
$1,365,930 |
D/D |
(15,177) |
57,196 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-05-23 |
4 |
OE |
$31.64 |
$480,200 |
D/D |
15,177 |
72,373 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2018-06-05 |
4 |
AS |
$92.45 |
$280,101 |
D/D |
(3,000) |
57,196 |
0 |
- |
|
121 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
